| Drug-resistant epilepsy: From multiple hypotheses to an integral explanation using preclinical resources D Pérez-Pérez, CL Frías-Soria, L Rocha Epilepsy & behavior 121, 106430, 2021 | 55 | 2021 |
| Drug‐resistant epilepsy: Drug target hypothesis and beyond the receptors D Fonseca‐Barriendos, CL Frías‐Soria, D Pérez‐Pérez, R Gómez‐López, ... Epilepsia Open 7, S23-S33, 2022 | 26 | 2022 |
| A pilot randomized controlled clinical trial of Transcranial Alternating Current Stimulation in patients with multifocal pharmaco-resistant epilepsy D San-Juan, DA Espinoza-López, R Vazquez-Gregorio, C Trenado, ... Epilepsy & Behavior 130, 108676, 2022 | 16 | 2022 |
| Noninvasive transcranial focal stimulation affects the convulsive seizure-induced P-glycoprotein expression and function in rats D Pérez-Pérez, JL Castañeda-Cabral, S Orozco-Suárez, J Sotelo, ... Epilepsy & Behavior 115, 107659, 2021 | 15 | 2021 |
| Cannabidiol modifies the seizure expression and effects of antiseizure drugs in a rat model of recurrent severe seizures CL Frías-Soria, D Pérez-Pérez, S Orozco-Suárez, L Rocha Seizure 90, 67-73, 2021 | 14 | 2021 |
| Methylxanthines: Potential therapeutic agents for glioblastoma D Pérez-Pérez, I Reyes-Vidal, EG Chávez-Cortez, J Sotelo, ... Pharmaceuticals 12 (3), 130, 2019 | 14 | 2019 |
| Polymorphisms in β-adrenergic receptors are associated with increased risk to have a positive head-up tilt table test in patients with vasovagal syncope MF Márquez, JM Fragoso, D Pérez-Pérez, I Cázares-Campos, ... Revista de investigación clínica 71 (2), 124-132, 2019 | 13 | 2019 |
| Protein expression of P-glycoprotein in neocortex from patients with frontal lobe epilepsy D Fonseca-Barriendos, D Pérez-Pérez, M Fuentes-Mejía, ... Epilepsy Research 181, 106892, 2022 | 7 | 2022 |
| Transcranial Focal Electrical Stimulation Modifies Biogenic Amines’ Alterations Induced by 6-Hydroxydopamine in Rat Brain CE Santana-Gómez, D Pérez-Pérez, D Fonseca-Barriendos, ... Pharmaceuticals 14 (8), 706, 2021 | 2 | 2021 |
| Modulating P-glycoprotein Regulation as a Therapeutic Strategy for Pharmacoresistant Epilepsy D Perez-Perez, H Luna-Munguia, H Potschka Pharmacoresistance in Epilepsy: From Genes and Molecules to Promising …, 2023 | 1 | 2023 |
| Study of genetic variants and their clinical significance in Mexican pediatric patients with epilepsy IA Feria-Romero, A Reyes-Cuayahuitl, J Sosa-Maldonado, ... Gene 877, 147565, 2023 | 1 | 2023 |
| Preclinical efficacy profiles of the sigma‐1 modulator E1R and of fenfluramine in two chronic mouse epilepsy models D Pérez‐Pérez, C Monío‐Baca, EL von Rüden, V Buchecker, A Wagner, ... Epilepsia 65 (8), 2470-2482, 2024 | | 2024 |
| Neuromodulation of Bilateral Hippocampal Foci, an Alternative for Mesial Temporal Lobe Seizures in Patients with Non-Lesional MRI: Long-Term Follow-up F Velasco, D Vázquez-Barrón, D Pérez-Pérez, M Cuéllar-Herrera, D Trejo, ... Epilepsy J 2 (116), 2472-0895.1000116, 2016 | | 2016 |
| The Use of Anti-inflammatory Drugs in Epilepsy MG Valle-Dorado, LE Córdova-Dávalos, D Pérez-Pérez, ... Antiepileptic Drug Discovery: Novel Approaches, 23-36, 2016 | | 2016 |
Luisa RochaDepto. Farmacobiología, Centro de Investigación y de Estudios Avanzados del IPNVerified email at cinvestav.mx
